BioSpace News Archive

Jeffrey Chodakewitz, M.D., to retire and serve as senior advisor through early 2019. Dr. Kewalramani to become CMO and Executive Vice President, Global Medicines Development and Medical Affairs, on April 1, 2018.

Study in The Journal of the American Osteopathic Association Suggests Up to 50 Percent of U.S. Population is Magnesium Deficient

Bioventus, a global leader in orthobiologic solutions, has entered into an agreement with LifeLink Tissue Bank, a division of LifeLink Foundation, Inc. headquartered in Tampa, FL, to co-develop a next generation bone allograft solution for use in spine and trauma surgery.

Maxinovel Pharmaceuticals today announces that it will present preclinical results of its orally active PD-1/PD-L1 inhibitors as a single agent or combination with Epacadostat, Celebrex, Cisplatin and CTLA-4, respectively.

Agriculture Division to be Corteva Agriscience™, reflecting its purpose of enriching the lives of those who produce and consume. Materials Science Division will be called Dow, and will retain the Dow diamond as its brand, building on the Company’s globally recognized 121-year history of innovation and value creation. Specialty Products Division to be the new DuPont, carrying forward a 215-year legacy of science-based innovation to transform industries and everyday life.

DanDrit Biotech USA, Inc. finalized its acquisition of Enochian Biopharma Inc. on February 16, 2018.

Neumentum today announced it has confirmed its Type B meeting with the U.S. Food and Drug Administration (FDA).

The current influenza season has been especially difficult, causing widespread illness that has affected all fifty states and resulted in a record number of hospitalizations. While healthcare professionals continue to combat...

NuVasive, Inc. announced today financial results for the quarter and full year ended Dec. 31, 2017.